Blog
About

  • Record: found
  • Abstract: found
  • Article: not found

Evidence-based recommendations for the prevention and long-term management of thrombosis in antiphospholipid antibody-positive patients: report of a task force at the 13th International Congress on antiphospholipid antibodies.

Lupus

therapy, Advisory Committees, Antibodies, Antiphospholipid, adverse effects, blood, Antiphospholipid Syndrome, complications, immunology, Clinical Trials as Topic, Congresses as Topic, Female, Humans, Pregnancy, Texas, Thrombosis, etiology, prevention & control

Read this article at

ScienceOpenPublisherPubMed
Bookmark
      There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

      Abstract

      The antiphospholipid syndrome (APS) is defined by the presence of thrombosis and/or pregnancy morbidity in combination with the persistent presence of circulating antiphospholipid antibodies: lupus anticoagulant, anticardiolipin antibodies and/or anti-β2-glycoprotein I antibodies in medium to high titers. The management of thrombosis in patients with APS is a subject of controversy. This set of recommendations is the result of an effort to produce guidelines for therapy within a group of specialist physicians in Cardiology, Neurology, Hematology, Rheumatology and Internal Medicine, with a clinical and research focus on APS.

      Related collections

      Author and article information

      Journal
      10.1177/0961203310395803
      21303837

      Comments

      Comment on this article